Resources
BioMed Alliance replies to consultation on HTA Implementing Regulation
BioMed Alliance replied to the public consultation on the HTA Implementing Regulation on joint clinical assessments of medicinal products. In the reply, BioMed Alliance argues that the involvement of...
New multistakeholder statement on EHDS
The BioMed Alliance has contributed to a joint statement issued by a large multistakeholder group, representing the entire spectrum of the healthcare ecosystem and consisting of 35 European patient or...
Multistakeholder statement on EHDS
The BioMed Alliance has contributed to a joint statement issued on 26 February 2024 by a large multistakeholder group, representing the entire spectrum of the healthcare ecosystem and consisting of 35...
Healthcare professionals and researchers share recommendations for trilogue discussions on EHDS
The BioMed Alliance has published a new statement in light of the trilogue discussions on the proposal for a European Health Data Space. Medical societies, and the healthcare professionals and researc...
Recommendations trilogue negotiations EHDS
On 20 February 2024, BioMed Alliance published a new statement in light of the trilogue discussions on the proposal for a European Health Data Space. In the statement, we draw attention to some of the...
Statement advocates for a balanced approach to phasing out PFAS
In a new statement, BioMed Alliance provides insight on the harmful impacts of Per- and polyfluoroalkyl substances (PFAS) and urges manufacturers of medical devices to find safe alternatives whilst en...
Urgent action needed to prevent widespread shortage of diagnostic tests
In a statement from January 2024, BioMed Alliance highlights its increasing concerns about approaching widespread issues with the availability of In Vitro Diagnostic Devices (IVDs) in Europe.
Per...
Stakeholder coalition statement calls for legislative refinement of the EHDS
Together with a large multi-stakeholder group, representing the entire spectrum of the healthcare ecosystem and consisting of 36 European patient organisations, medical associations, health research i...
ENVI-LIBE vote on EHDS does not take into account recommendations scientific community
The BioMed Alliance is disappointed to see a partial opt-in approach for the re-use of health data for research in the new ENVI-LIBE position on the European Health Data Space (EHDS). The committees...
BioMed Alliance replies to consultation on the revision of the EU Pharmaceuticals legislation
On 8 November, the BioMed Alliance submitted its public reply to the Consultation on the Revision of the EU general pharmaceuticals legislation. The Commission proposal which entails a substantial rev...
Statement calling on policy makers to avoid putting an emergency break of life-saving research through EHDS
In a statement from November 2023, the BioMed Alliance urgently calls on policy makers to take action to ensure the European Health Data Space (EHDS) will not severely jeopardise health research. The...
Urgent call on MEPs and Member States to act now to avoid putting an emergency brake on life-saving health research through EHDS
In a new statement, the BioMed Alliance urgently calls on policy makers to take action to ensure the European Health Data Space (EHDS) will not severely jeopardise health research. The health research...